Advertisement
Screener

Twist Bioscience Corporation (TWST) Profit Breakdown

Twist Bioscience Corporation (TWST) Profit Breakdown

  • 2026-06-30: Reportable -$34.74M.
  • 2025-06-30: Reportable $20.58M.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2017-09-30 to 2026-06-30
Data captured

Profit by product

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest: each quarter (3 month)

Quarter endReportable
2026-06-30-$34.74M
2025-06-30$20.58M

Net Income (Loss) Attributable to Parent: each quarter (3 month)

Quarter endReportable
2026-06-30-$35.05M
2025-06-30$20.39M

Operating income: each quarter (3 month)

Quarter endReportable
2026-06-30-$36.28M
2025-06-30-$30.12M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78